Reactogenicity Following Receipt of mRNA-Based COVID-19 Vaccines
6 Apr, 2021 | 01:21h | UTCReactogenicity Following Receipt of mRNA-Based COVID-19 Vaccines – JAMA
Commentaries on Twitter
This @JAMA_current paper summarizes adverse reactions to mRNA #COVID19 vaccines through @CDCgov v-safe surveillance system, which collects near–real-time data via smartphone text message prompts and web-based health surveys. https://t.co/Xbdg0lxYfK pic.twitter.com/E4q13aJfkZ
— Muin J. Khoury (@MuinJKhoury) April 5, 2021
.@CDCgov's v-safe program collects near–realtime data from US #COVID19 vaccine recipients. V-safe participants self-enroll and receive smartphone text messages to initiate web-based health health surveys from the day of vaccination (day 0) through 12 mo https://t.co/utJNibTTd9
— JAMA (@JAMA_current) April 5, 2021